longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Intuitive Surgical

ISRG

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfileWeekly ReviewWeekly Review
LongbridgeAI

Current ValuationThe current P/E ratio is 43.17, below the reasonable range, cheaper than 96.62% of the time in the past 5 years, and the industry ranks 38/175, the industry Median -0.88.

43.17xP/E
$383.54Stock price
$8.88Earnings per share
43.17xP/E
Stock price$383.54Earnings per share$8.88

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
70.27x
Typical range
58.27x–78.52x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
011223344

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
ABTUSAbbott Laboratories
32.97x5.11%$178.05B
ISRGUSIntuitive Surgical
43.17x17.25%$135.50B
IDXXUSIDEXX Labs
35.01x12.89%$39.90B
DXCMUSDexCom
33.19x19.36%$33.18B
ITGRUSInteger
33.44x5.33%$4.29B
NVSTUSEnvista
40.05x313.05%$3.81B
OMCLUSOmnicell
38.07x2,358.33%$1.49B
VREXUSVarex Imaging
35.36x127.65%$781.42M
MBAIUSMBody AI
36.38x--$18.47M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.